Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a monoclonal antibody therapy for lymphoproliferative disorder associated with immunosuppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Lymphoma | Phase 2 | Status: COMPLETED